Extension of the Distributed Delay Approach to Model Delayed Outcomes Involving Loss Mechanism During the Delay Process 10월 8, 2018 By webdev
Development of a PBPK Model for Docetaxel as a CYP3A Substrate and Accounting for Binding to Multiple Plasma Proteins 10월 8, 2018 By webdev
Interpretation of Dose-dependent Pharmacokinetics of Ruzasvir Using Both Physiologically-based Pharmacokinetic and Population Pharmacokinetic Modeling Approaches 10월 8, 2018 By webdev
Development of a Pre-clinical Quantitative Systems Pharmacology Model for E7046, a Novel PGE2 Receptor Type 4 Antagonist for Cancer Immunotherapy 10월 8, 2018 By webdev
Clinical Trial Simulation (CTS) for a New Rapidly Absorbed Paracetamol Formulation (NP) Development from the Conventional Paracetamol Tablet (CP) 10월 8, 2018 By webdev
Impact of Free Fatty Acids on Prediction of Unbound Fraction of Cefazolin and Diazepam in Plasma of Full-term Neonates 10월 8, 2018 By webdev
Application of Feto-maternal Physiologically-based Pharmacokinetic Model to Predict Emtricitabine Concentration During Pregnancy 10월 8, 2018 By webdev
Modeling Double Peak Phenomenon and In Vitro-In Vivo Correlation (IVIVC) in Pharmacokinetics (PK) for Clinical Trial Simulation (CTS) of Virtual Bioequivalence (BE) Studies 10월 8, 2018 By webdev
Development of a Population Pharmacokinetic Model for Binimetinib with Subsequent Exposure-response Analyses in NRAS Mutant Melanoma 10월 8, 2018 By webdev
A Product-profile-driven Clinical Utility Index (CUI) Analysis to Balance Benefits and Risks for Dose Selection in Oncology 10월 8, 2018 By webdev